AKT1 and breast cancer: To evaluate the role of the PI3K/Akt/mTOR pathway in the antitumour effects of PF-04691502, BC cells were transfected with a vector constitutively expressing activated myristoylated Akt (myr-Akt) according to a previous study [6].